CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS([*]), HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24B-2 OF THE EXCHANGE ACT OF 1934, AS AMENDED RESEARCH,...Certain Confidential Information • June 5th, 2006 • Combinatorx, Inc • Pharmaceutical preparations • Maryland
Contract Type FiledJune 5th, 2006 Company Industry JurisdictionTHIS RESEARCH, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT is made this day of May, 2006, (the “Effective Date”) (the “Agreement”), by and between CombinatoRx, Incorporated (“CombinatoRx”), a Delaware corporation with principal offices at 245 First Street, Cambridge, MA, 02142 (“CombinatoRx”), and Cystic Fibrosis Foundation Therapeutics Incorporated, a Maryland corporation with principal offices at 6931 Arlington Road, Bethesda, Maryland 20814 (“CFFT”). CombinatoRx and CFFT may each be referred to as a “party” and collectively, as the “Parties.”